Description

RT10 Retatrutide    10mg*10vials
Description
Properties
Safety & handling
Product Overview
Retatrutide is a modified peptide used in laboratory studies of GIP, GLP-1 and glucagon receptor signalling, triple-receptor pharmacology, peptide characterisation and metabolic pathway research. The material is intended for qualified research organisations, analytical laboratories and product-development teams. It is supplied under batch-controlled conditions, and the final website specification must match the released COA.
Key Features
• Product type: Triple GIP/GLP-1/Glucagon Receptor Agonist Peptide
• Featured specification: 30 mg / 3 mL per vial; 10 vials per box
• Purity / grade: ≥99.6% by HPLC, subject to the batch COA
• Appearance: White to off-white lyophilized powder; confirm against the batch COA
• Documentation: Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable
• Bulk supply and custom labelling are available subject to technical and compliance review
• Minimum order: 100 boxes (1,000 vials)
Research Applications
Typical non-clinical research use includes triple receptor agonists, receptor or enzyme assays, peptide or small-molecule characterisation, chromatographic method development, mass-spectrometric confirmation, stability assessment and formulation compatibility studies. Researchers should determine suitability for their own protocol.
Supply & Quality Documentation
Batch-specific quality documentation is available according to the selected grade and order. Technical values shown on the website should be reconciled with the final COA, HPLC and MS results before release. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Frequently Asked Questions
What is Retatrutide?
Retatrutide is a modified peptide used in laboratory studies of GIP, GLP-1 and glucagon receptor signalling, triple-receptor pharmacology, peptide characterisation and metabolic pathway research. It is supplied solely for qualified laboratory research.
What specifications are available for Retatrutide?
Current catalogue specifications are 5 mg, 10 mg, 15 mg, 20 mg, 22 mg, 24 mg, 30 mg, 36 mg, 40 mg, 50 mg, 60 mg; 10 vials per box. Final availability must be confirmed when requesting a quotation.
What purity is supplied?
≥99.6% by HPLC, subject to the batch COA. The batch COA is the controlling quality record.
Which quality documents are available?
Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable. Document availability depends on the selected grade and batch.
How should Retatrutide be stored?
Store sealed at 2−8°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
Is Retatrutide intended for human use?
No. It is supplied for laboratory research only and is not intended for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Quality & Documentation
Safety Data Sheet (SDS), Certificate of Analysis (COA) and specification documents can be supplied with your quotation.